Merck & Co., Inc. EVP David Michael Williams recently sold 5,000 shares of MRK stock for over $609,000, reducing his stake by nearly 14%. This sale is part of broader insider selling by top executives, which could concern investors. Despite these sales, Merck’s fundamentals remain strong, with Q4 earnings exceeding expectations, positive FY-2026 EPS guidance, and a declared quarterly dividend of $0.85.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Merck & Co., Inc. (NYSE:MRK) EVP David Michael Williams Sells 5,000 Shares
Merck & Co., Inc. EVP David Michael Williams recently sold 5,000 shares of MRK stock for over $609,000, reducing his stake by nearly 14%. This sale is part of broader insider selling by top executives, which could concern investors. Despite these sales, Merck’s fundamentals remain strong, with Q4 earnings exceeding expectations, positive FY-2026 EPS guidance, and a declared quarterly dividend of $0.85.